Sunday, February 14, 2010

ABBOTT PROFIT HURT BY DOLLAR AND GENERICS



Abbott Laboratories second-quarter earnings fell 2.6 percent, with competition for its anti-seizure drug overshadowing strong sales of its arthritis drug.

Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)